Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

28.6%

2 terminated/withdrawn out of 7 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 3

1(16.7%)

Phase 4

1(16.7%)

6Total

N/A(4)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07621172Completed

Long-term Safety and Efficacy of CartiFill After Microfracture Surgery in Knee Cartilage Defects

Role: lead

NCT02539095Phase 4Completed

Efficacy of Intra-articular Collagen Injection in Patients With Knee Joint Pain Compared to Normal Saline Injection

Role: lead

NCT07511777Not ApplicableCompleted

Clinical Trial to Assess the Safety and Efficacy of Intra-articular Injection Collagen Versus Hyaluronic Acid on Knee Osteoarthritis

Role: lead

NCT07518836Not ApplicableTerminated

Efficacy and Safety of SurgiFill™in Patients With Femur or Tibia Fracture

Role: lead

NCT02539069Not ApplicableCompleted

The Post-marketing Surveillance to Evaluate the Efficacy of CHONDRON (Autologous Cultured Chondrocyte) by Arthroscopy

Role: lead

NCT02539056Not ApplicableCompleted

The Post-marketing Surveillance to Evaluate the Efficacy and Safety of a CHONDRON (Autologous Cultured Chondrocyte)

Role: lead

NCT02537067Phase 3Terminated

Efficacy and Safety of Chondron (Autologus Chondrocyte) in Patients With Cartilage Defects in Their Ankle

Role: lead

All 7 trials loaded